Biologic Drugs With Mechanism of Action: Classical Complement Pathway Inhibitors
✉ Email this page to a colleague
Biologic Drugs With Mechanism of Action: Classical Complement Pathway Inhibitors
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bioverativ Therapeutics, Inc. | ENJAYMO | sutimlimab-jome | Injection | 761164 | 2022-02-04 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |